The Inceptiv data give Medtronic more evidence as it tries to increase sales of a product that drove double-digit growth at ...
Ameritas Advisory Services LLC bought a new position in shares of Boston Scientific Co. (NYSE:BSX – Free Report) during the 4th quarter, according to the company in its most recent filing with the ...
Boston Scientific Corporation develops ... neurological movement disorders and manage chronic pain, such as spinal cord stimulator system, proprietary programming software, radiofrequency ...
Atalanta Therapeutics is building on the growing attention around RNAi-based medicines with its $97 million Series B financing and plans to enter the clinic.
In this article, we are going to take a look at where Boston Scientific Corp (NYSE:BSX) stands against the other medical AI stocks. Investments in the global healthcare industry have ramped up ...
Medtronic (NYSE: MDT) today announced 12-month data demonstrating the benefits of its Inceptiv closed-loop spinal cord stimulator (CL-SCS).
In a new study, scientists at the Leibniz Institute for Neurobiology (LIN) and University Hospital Magdeburg demonstrated ...
© 2025 American City Business Journals. All rights reserved. Use of and/or registration on any portion of this site constitutes acceptance of our User Agreement ...
Deutsche Bank has recently raised Boston Scientific Corp (BSX) stock to Buy rating, as announced on January 10, 2025, according to Finviz. Earlier, on October 18, 2024, Needham had reduced the stock ...
Neurostimulation Devices market Research Report. WILMINGTON, DE, UNITED STATES, January 29, 2025 /EINPresswire / -- As of 2018, the global neurostimulation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results